the bioactivities of individual lipid and fatty acid molecules which is starting to be reflected in dietary recommendations 2 .
There is considerable dietary fatty acid intake data in the literature. A recent global summary of national nutrition surveys identified considerable variation in the intakes of the classes of fatty acids and dietary cholesterol, and identified concerns about low intakes of polyunsaturated fatty acids PUFA , particularly omega-3 PUFA derived from seafood in across the globe 5 . Unfortunately, information on the intake of individual fatty acids was not examined in this review. When the intake of individual fatty acid are examined, palmitate 16:0 , stearate 18:0 , oleate 18:1n-9 and linoleate 18:2n-6 comprise approximately 90 of the total fatty acids consumed across various industrialized countries Table 1 . However, the contribution of these four main dietary fatty acids can fall below 50 of the total fatty acid intake in populations consuming a hunter/gatherer based diet 7 . Interestingly, the intake of fatty acids in the traditional Greenland Inuit diet 7 . These dietary fatty acids are mainly believed to be in the form of triacylglycerols 11 . It has been estimated that triacylglycerols make up 95 of the total fat consumed with phospholipids contributing 4.5 and sterols and other lipids making up the remaining 0.5 12 . Precise quantitative data on the type of complex lipids consumed is limited as nutrition databases contain the fatty acid and cholesterol content of food items rather than the naturally occurring chemical form of lipids. Lipidomic analytical approaches has the potential to characterize and quantitate the intake of complex lipid species. Lipidomics has emerged as a field of study due to the advancements of analytical tools, particularly increased usability of liquid chromatography coupled to tandem mass spectrometry LC-MS/MS . Lipidomic initiatives have led to numerous advances including the development of a nomenclature and classification system for lipids 13 but methodologies continue to evolve and truly comprehensive quantitation of complex lipids remain elusive due to the structural complexity and the diversity in abundancies of the various lipids in biological samples 14 . The aim of this review is to revisit the role of fatty acid biomarkers in understanding diet and health with the emergence of lipidomic analyses. This will include an overview of biomarkers of fat intake and challenges in establishing the biomarkers as indicators of health status and disease risk. The role of fatty acids within metabolism and the challenges they present within the field of lipidomics will be examined. This will include an example of how lipidomic based approaches can provide additional insight into lipid metabolism that are not available with fatty acid determinations.
Fatty Acids as Biomarkers
Blood biomarkers can improve the assessment of dietary fat intakes beyond tools such as dietary records and food frequency questionnaires 15 17 . The relationship between dietary intakes of specific fatty acids and their corresponding blood levels was examined in the early 1990s 18 which demonstrated high diagnostic values for blood levels of n-3 and n-6 PUFA in comparison to saturated and monounsaturated fatty acids. This is largely dictated on the dependency of diet as a source of PUFA whereas saturates and monounsaturates can be generated de novo from the carbon backbones of carbohydrates and amino acids. Biomarkers of dietary fat consumption can be based on fatty acid analyses of various tissues and fluids 19 , and although adipose tissue is often preferred for the assessment of long term dietary intake, the use blood based biomarkers are more feasible for routine sample collection 20, 21 .
Biomarkers of omega-3 PUFA
Omega-3 PUFA intakes have been associated with various health benefits, including a decreased risk of cardiovascular mortality 22 , support of neural development 23 and a reduced risk of inflammatory based diseases such as asthma 24 . However, the strength of these health benefits are not reported across studies consistently which has been examined and discussed 25 . One of the major concerns is the lack of accurate determinations of background diet and poor measures of compliance/adherence to omega-3 PUFA intervention 26 . Most clinical trials claim high adherence to omega-3 PUFA intervention despite the literature indicating that changing dietary behaviour is very difficult 27 . These claims of high adherence are usually based on simple surveys and/or capsule count to determine intake which are unreliable due to response bias 28 . Examining adherence to omega-3 PUFA intervention by measuring blood fatty acid levels can be more informative 17, 29 .
Various blood measures reflecting omega-3 PUFA blood status have been proposed 30 , and large regions of the world have been shown to have low blood levels of omega-3 PUFA 31 . The most commonly used omega-3 PUFA biomarker is the omega-3 index which was first proposed as a potential risk factor for coronary heart disease 32 . Despite the success of the omega-3 index , the acceptance and 33 . These best practices were not prescriptive towards a single gold standard as it was recognized that the type of research and the research questions could vary and these need to be considered in the analytical choices. However, it was established that the analytical choices need to be well documented and justified, especially for; 1 sample collection including the type of sample and the storage conditions, 2 chemical preparation of the sample such as lipid extraction/isolation and fatty acid derivitization, 3 instrument analyses such as gas chromatography coupled to flame ionization detection or mass spectrometry, and 4 data analysis and reporting including the number of fatty acids to report and the manner/units to express the data. Ultimately, standardization of fatty acid measurements will improve reproducibility and consistency in study outcomes.
Fatty Acids within a Lipidomic Approach
Fatty acids as free or non-esterified fatty acids are relatively limited in human biology. Most of the dietary fat consumed is in the chemical form of triacylglycerols, with three fatty acyls esterified to a glycerol backbone. Digestion and absorption initiates their chemical rearrangement as lipases hydrolyze fatty acids from their dietary precursors but they are quickly repackaged as fatty acyls within the complex lipids of chylomicrons before entering the circulation. The chylomicrons then release fatty acids and triacylglycerols to tissues, with hepatic lipid metabolism playing a central role in the fate of fatty acids through uptake, biosynthesis, elongation, desaturation, and lipoprotein assembly. Adipose sites serve as reservoirs of triacylglycerols, than can release free fatty acids to the circulation to support energy demand. These are free or nonesterified fatty acids complex with albumin for transport in the plasma to cardiac, skeletal muscle and hepatic tissues. At the tissue, fatty acids dissociate from albumin and translocate across the cell membrane and into the cell 34, 35 .
Within the cell, various enzymes are involved in fatty acid release from and incorporation into complex lipids such as lipases, acyl-CoA synthetases and acyltransferases that can reshape the acyl species of complex lipids 36 38 . There is evidence that certain fatty acids are preferentially placed within certain complex lipids. For example, highly unsaturated fatty acids HUFA, ≥ 20 carbons and ≥ 3 carbon-carbon double bonds are preferentially incorporated into the sn-2 position of glycerophopholipids 39 43 . In contrast, erythrocytes consist of a more complex mixture of membrane polar lipids and very little of the nonpolar triacylglycerol and cholesteryl ester fractions. Whole blood is obviously a mixture of these lipidomic profiles, and while not analyzed as frequently as plasma and erythrocytes, lipidomic analysis of dried blood spots is possible 44 .
The plasma lipidome has received the most attention in regards to standardization of lipidomic measurements of a blood fraction based on the clinical availability and the availability of plasma based standard reference materials 42 .
However, the plasma lipidome is not as well defined as it should be. A recent interlaboratory exercise revealed considerable variation in what was measured and reported, with over 1500 unique lipids being measured but consensus location estimates and associated uncertainities were determined for only 339 lipids 41 . This variation indicates a lack of standardized protocols, but also highlights that the lipidomic field is a mixture of researchers with interests and analytical procedures for specific types of lipids to answer individual research questions. Full characterization of the plasma lipidome appears to require several quantitative analytical procedures 45 , but even then not all lipid classes are examined at the same level of detail. In general, there is a tendency for lipidomics to focus on the detailed analysis of low abundant and highly bioactive lipid mediators, rather than full characterization of acyl species of complex lipids 41 .
Analytical Approaches
Initiatives to standardize blood lipidomic approaches are ongoing and have identified pre-analytical, analytical and post-analytical challenges that need to be considered and are presented in detail elsewhere 42 . The variety of analyti-cal platforms and techniques available to the mass spectrometrist is a boon in the pursuit of identifying different types of lipids, but makes the acceptance of standardized protocols challenging. Shotgun approaches in lipidomics with minimized sample preparation and direct infusion can increase sample throughput, but proper identifications in very complex samples and quantitative results can be difficult. Front-end separation of analytes prior to mass spectrometry such as liquid chromatography can improve identifications in global or untargeted approaches but quantitation remains a challenge and throughput decreases due to the additional time for separation. The use of targeted approaches provide the best quantitative results, but by definition, the analytes are predetermined, which one could argue is no longer a true omic endeavour. Previously, we have proposed categorizing types or the focus of a lipidomic approach on the abundancy of the analytes being measured 46 to shift the focus on the lipidology rather than the analytical conditions. Examining high abundant lipids is considered macrolipidomics and examining low abundant lipids is microlipidomics . Macrolipidomics examines common structural and energy storage lipids and methods could potentially be standardized as common sample preparation techniques could be established relatively easily. Microlipidomics examines the highly bioactive and transient lipid signalling molecules that require targeted approaches for proper determinations as how the sample is collected, stored and processed can impact the type and concentration of the analyte measured.
Levels of Information in Macrolipidomics
Macrolipidomics has a considerable focus on highly abundant complex lipids that contain fatty acyl chains. The level of information reported about the fatty acyl containing lipids varies considerably in the literature 47 . Unfortunately, the practice of reporting the lowest level of information about fatty acyl containing complex lipids is common 41 . This lowest level is known as the sum compositional level or brutto level where the lipid class followed by the total number of carbons and double bonds across all the constituent fatty acyl chains 46 . For nutritional research, brutto information can severely limit the ability to determine the acyl species of complex lipids as various combinations of fatty acids can make up a singular brutto definition as a phosphatidylcholine PC with a sum composition of 38:6 could be PC 16:0_22:6, PC 16:1_22:5, PC 18:1_20:5, PC 18:2_20:4, or PC 18:3_20:3. For macrolipidomic data to be informative to the nutritional scientist, information about the distinct acyl chains or the specific isomer of the complex is required, which we have defined as medio level of information 46 . This medio level of information is defined by an underscore between the acyl chains i.e. PC 16:0_22:6 to denote that the sn location of each acyl chain within the lipid is unknown. Tandem mass spectrometry is typically required to confirm the acyl chain fragments of the parent lipid. The acyl MS/MS fragmentation patterns can also inform the analyst of the location of the acyl chains, as the acyl in the sn-2 of a phospholipid will be more abundant than that in the sn-1 position. Knowing distinct regio-isomers has been termed as the genio level of information 46 and are denoted by a forward slash between the ordered fatty acyls such as PC 16:0/22:6 versus PC 22:6/16:0. Finally, the infinio level of information is reserved for cases when geometric cis vs trans and positional carbon-carbon double bond location isomers of the fatty acyls within the complex lipid are known 46 . While it is possible to determine infinio levels of information with tandem mass spectrometry, it requires specialized analytical procedures 48 . In nutritional research, various dietary databases contain information the individual fatty acid content of foods 5 . Therefore, the minimum standard level of information for macrolipidomic analyses of complex lipids needs to be at the medio level to provide useful nutritional insights. While genio and infinio levels would provide additional information, the increased analytical effort at this time to acquire such information is a considerable burden.
Using Macrolipidomics to Examine Maternal Docosahexaenoic Acid Status during Pregnancy
Recently, we demonstrated the value of using a lipidomic approach in a nutritional research study examining fatty acid metabolism during pregnancy 40 . Maternal DHA levels are important for infant health 24, 49 and there is evidence of metabolic adaptions during pregnancy to increase blood levels of DHA 50 . From fatty acid metabolism studies, the increased blood levels of maternal DHA during pregnancy appear to be driven by increased biosynthesis from other omega-3 PUFA precursors through upregulated Δ6 desaturase or FADS2 because of increased circulating estradiol 51, 52 .
Using traditional fatty acid techniques in a rodent model of pregnancy, we were able to determine that that the increase in plasma DHA that is associated with pregnancy was mainly in the PC fraction 40 . PC is a major component of lipoproteins. During pregnancy, hepatic lipoprotein assembly and secretion into the plasma is upregulated 53 . PC in lipoproteins have the potential to serve as a source of fetal fatty acids as the placenta has considerable phospholipase activity 54 . Using lipidomic analyses, we identified that the increase in plasma DHA was largely due to increases in PC 16:0/22:6. With this insight, the metabolic pathways that could be involved with the specific hepatic synthesis of PC 16:0/22:6 were examined. PC is synthesized de novo through the Kennedy pathway or by methylation of phosphatidylethanolamine PE by PE methyltransferase PEMT 55 . With de novo synthesis, the fatty acyl composition can be immature in the initial phospholipid, which can then be remodelled through the Land s cycle 56 . The incorporation of DHA into phospholipids occurs during this remodelling through an acyl transferase, or in the case of PC remodelling, a lysophosphatidylcholine acyltransferase LPCAT . A LPCAT with a high specificity for DHA has not been identified 37 suggesting that other mechanisms are involved in the hepatic synthesis of PC 16:0/DHA during pregnancy. PEMT is upregulated during pregnancy as determined by studies examining choline metabolism 57 , which we confirmed in our rodent model 40 . The DHA content of PE is typically higher than the DHA content of PC 58 , therefore increased hepatic methylation of PE by PEMT during pregnancy could be a mechanism of increased DHA in maternal PC. In primary cultures of rat hepatocytes, Ridgway and Vance demonstrated that newly PC formed by PEMT from PE is highly enriched in PC 16:0_DHA as compared with other lipid species 55 . The mechanistic insights gained from a lipidomic approach in this study highlight the potential mechanistic insight that can be gained from the use of lipidomics in nutritional fatty acid and lipid research.
Conclusions
Fatty acid levels in blood are useful biomarkers of dietary intake and can be used to determine associations between specific fatty acids and various health outcomes in large observational studies. In clinical intervention trials, fatty acid blood biomarkers can confirm background dietary intakes and assess adherence to intervention protocols. This information is important to understand the effectiveness of interventions and to determine target intake levels for dietary recommendations. Lipidomic blood biomarkers have the potential to be even more informative than fatty acid biomarkers as the location of the fatty acyls within the complex lipids are not lost during analysis. In particular, lipidomic analyses will raise the mechanistic understanding of the role of fatty acids and lipids in health. The routine use of lipidomics is currently limited by a lack of standardization of methodological approaches, a lack of consensus on what and how to report lipidomic data, and challenges in quantifying the diverse types of biological lipids. These challenges become less daunting when lipidomics is categorized into macrolipidomics and microlipidomics according to the abundance of lipids in a biological sample. In addition, for lipidomics to be fully embraced in nutritional research, the reporting of sum compositional data or brutto species of lipids needs to be discontinued in favour of reporting medio, genio or infinio species.
